Destination: The aim of this RFP is to further develop and validate established biomarkers for which there is a clear clinical need in Alzheimer’s disease and related dementias. This RFP prioritizes biomarkers with a defined context of use, a clear advantage over other relevant biomarkers, and a path to commercialization and/or clinical use. Specifically, this RFP focuses on:
Budget: Up to 600,000 $ based on stage and scope of research.
Duration: 1 year with potential for follow-on funding.
Llena el siguiente formulario para recibir más información: